CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-31 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,309 | $121.62 | $159K | 2,224,015 |
| 2024-07-24 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,668 | $116.33 | $310K | 2,251,347 |
| 2024-07-24 | AFEYAN NOUBAR Director | Sale 10b5-1 | −3,500 | $117.25 | $410K | 2,247,847 |
| 2024-07-24 | AFEYAN NOUBAR Director | Sale 10b5-1 | −6,832 | $118.30 | $808K | 2,241,015 |
| 2024-07-24 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,000 | $119.01 | $238K | 2,239,015 |
| 2024-07-17 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,601 | $120.86 | $314K | 2,266,414 |
| 2024-07-17 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,100 | $121.57 | $255K | 2,264,314 |
| 2024-07-17 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,900 | $122.86 | $356K | 2,261,414 |
| 2024-07-17 | AFEYAN NOUBAR Director | Sale 10b5-1 | −6,699 | $123.82 | $829K | 2,254,715 |
| 2024-07-17 | AFEYAN NOUBAR Director | Sale 10b5-1 | −700 | $124.61 | $87K | 2,254,015 |
| 2024-07-15 | Hoge Stephen President | Sale 10b5-1 | −15,000 | $121.12 | $1.8M | 1,442,089 |
| 2024-07-10 | AFEYAN NOUBAR Director | Sale 10b5-1 | −6,121 | $116.01 | $710K | 2,277,894 |
| 2024-07-10 | AFEYAN NOUBAR Director | Sale 10b5-1 | −4,279 | $117.18 | $501K | 2,273,615 |
| 2024-07-10 | AFEYAN NOUBAR Director | Sale 10b5-1 | −3,000 | $117.83 | $353K | 2,270,615 |
| 2024-07-10 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,100 | $119.28 | $131K | 2,269,515 |
| 2024-07-10 | AFEYAN NOUBAR Director | Sale 10b5-1 | −500 | $119.95 | $60K | 2,269,015 |
| 2024-07-08 | Mock James M Chief Financial Officer | Sale 10b5-1 | −689 | $118.24 | $81K | 7,269 |
| 2024-07-05 | Mock James M Chief Financial Officer | Exercise or conversion 10b5-1 | +1,452 | 7,958 | ||
| 2024-07-05 | Mock James M Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,452 | 13,075 | ||
| 2024-06-26 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,460 | $122.69 | $302K | 2,296,555 |
Page 25 of 38 · 743 trades